Anthracenedione drugs are typically administered intravenously. The dosage and schedule depend on the type and stage of cancer being treated, as well as the patient's overall health and treatment response. It is crucial for healthcare professionals to tailor the treatment plan to minimize risks and enhance therapeutic outcomes.
